Gastroesophageal reflux disease: Difference between revisions
Notjusttired (talk | contribs) m (Text replacement - "|author-link5=" to " | authorlink5 = ") |
Notjusttired (talk | contribs) m (Text replacement - ".| author" to ". | author") |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{stub}} | {{stub}} | ||
Gastroesophageal Reflux Disease or '''Gastro-esophageal Reflux Disease''' or GERD is a [[:Category:Digestive signs and symptoms|digestive disease]], GERD causes stomach contents to rise back up to the esophagus.<ref name="webmd">{{Cite web|url=https://www.webmd.com/heartburn-gerd/guide/reflux-disease-gerd-1 | title = Get the Facts About Gastroesophageal Reflux Disease (GERD)|website=WebMD|language=en|access-date=2021-03-03}}</ref> | Gastroesophageal Reflux Disease or '''Gastro-esophageal Reflux Disease''' or GERD is a [[:Category:Digestive signs and symptoms|digestive disease]], GERD causes stomach contents to rise back up to the esophagus.<ref name="webmd">{{Cite web | url = https://www.webmd.com/heartburn-gerd/guide/reflux-disease-gerd-1 | title = Get the Facts About Gastroesophageal Reflux Disease (GERD)|website=WebMD|language=en|access-date=2021-03-03}}</ref> | ||
==Signs and symptoms== | ==Signs and symptoms== | ||
Line 11: | Line 11: | ||
Over the counter medicals used for gastroesophageal reflux disease include the antacid mix [[aluminum hydroxide]]/magnesium hydroxide/simethicone (Almacone, Gelusil, Mi-Acid, Milantex), [[calcium carbonate]] (Titralac), and protein pump inhibitors including [[omeprazole]] (Prilosec), [[pantoprazole]] (Protonix), and [[famotidine]] (Pepcid).<ref name="drugscom" /> | Over the counter medicals used for gastroesophageal reflux disease include the antacid mix [[aluminum hydroxide]]/magnesium hydroxide/simethicone (Almacone, Gelusil, Mi-Acid, Milantex), [[calcium carbonate]] (Titralac), and protein pump inhibitors including [[omeprazole]] (Prilosec), [[pantoprazole]] (Protonix), and [[famotidine]] (Pepcid).<ref name="drugscom" /> | ||
Perscription medications for gastroesophageal reflux disease include [[omeprazole]] (Prilosec), [[pantoprazole]] (Protonix), [[ranitidine]] (Zantac, which was withdrawn from the market in the US), [[famotidine]] (Pepcid) and [[metoclopramide]].<ref name="drugscom">{{Cite web|url=https://www.drugs.com/condition/gastroesophageal-reflux-disease.html | title = List of GERD Medications (83 Compared)|website=Drugs.com|language=en|access-date=2021-03-03}}</ref> | Perscription medications for gastroesophageal reflux disease include [[omeprazole]] (Prilosec), [[pantoprazole]] (Protonix), [[ranitidine]] (Zantac, which was withdrawn from the market in the US), [[famotidine]] (Pepcid) and [[metoclopramide]].<ref name="drugscom">{{Cite web | url = https://www.drugs.com/condition/gastroesophageal-reflux-disease.html | title = List of GERD Medications (83 Compared)|website=Drugs.com|language=en|access-date=2021-03-03}}</ref> | ||
==ME/CFS== | ==ME/CFS== | ||
GERD is not a recognised comorbidity for people with [[ME/CFS]], although acid reflux may occur as part of a set of [[:Category:digestive signs and symptoms|Digestive symptoms]] according to the [[International Consensus Criteria]] primer for clinicians.<ref name="ICC2011primer">{{citation | last1 = Carruthers | first1 = BM | authorlink1 = Bruce Carruthers | last2 = van de Sande | first2 = MI | authorlink2 = Marjorie van de Sande | last3 = De Meirleir | first3 = KL | authorlink3 = Kenny de Meirleir | last4 = Klimas | first4 = NG | authorlink4 = Nancy Klimas | last5 = Broderick | first5 = G | authorlink5 = Gordon Broderick | last6 = Mitchell | first6 = T | authorlink6 = Terry Mitchell | last7 = Staines | first7 = D | authorlink7 = Donald Staines | last8 = Powles | first8 = ACP | authorlink8 = | GERD is not a recognised comorbidity for people with [[ME/CFS]], although acid reflux may occur as part of a set of [[:Category:digestive signs and symptoms|Digestive symptoms]] according to the [[International Consensus Criteria]] primer for clinicians.<ref name="ICC2011primer">{{citation | last1 = Carruthers | first1 = BM | authorlink1 = Bruce Carruthers | last2 = van de Sande | first2 = MI | authorlink2 = Marjorie van de Sande | last3 = De Meirleir | first3 = KL | authorlink3 = Kenny de Meirleir | last4 = Klimas | first4 = NG | authorlink4 = Nancy Klimas | last5 = Broderick | first5 = G | authorlink5 = Gordon Broderick | last6 = Mitchell | first6 = T | authorlink6 = Terry Mitchell | last7 = Staines | first7 = D | authorlink7 = Donald Staines | last8 = Powles | first8 = ACP | authorlink8 = AC Peter Powles | last9 = Speight | first9 = N | authorlink9 = Nigel Speight | last10 = Vallings | first10 = R | authorlink10 = Rosamund Vallings | last11 = Bateman | first11 = L | authorlink11 = Lucinda Bateman | last12 = Bell | first12 = DS | authorlink12 = David Bell | last13 = Carlo-Stella | first13 = N | authorlink13= Nicoletta Carlo-Stella | last14 = Chia | first14 = J | authorlink14= John Chia | last15 = Darragh | first15 = A | authorlink15= Austin Darragh | last16 = Gerken | first16 = A | authorlink16= Anne Gerken | last17 = Jo | first17 = D | authorlink17= Daehyun Jo | last18 = Lewis | first18 = DP | authorlink18= Donald Lewis | last19 = Light | first19 = AR | authorlink19= Alan Light | last20 = Light | first20 = KC | authorlink20= Kathleen Light | last21 = Marshall-Gradisnik | first21 = S | authorlink21= Sonya Marshall-Gradisnik | last22 = McLaren-Howard | first22 = J | authorlink22= John McLaren-Howard | last23 = Mena | first23 = I | authorlink23= Ismael Mena | last24 = Miwa | first24 = K | authorlink24= Kunihisa Miwa | last25 = Murovska | first25 = M | authorlink25= Modra Murovska | last26 = Stevens | first26 = SR | authorlink26= Staci Stevens | title = Myalgic encephalomyelitis: Adult & Paediatric: International Consensus Primer for Medical Practitioners | date = 2012 | ||
| isbn = 978-0-9739335-3-6 | url = http://www.investinme.org/Documents/Guidelines/Myalgic%20Encephalomyelitis%20International%20Consensus%20Primer%20-2012-11-26.pdf }}</ref><ref name="canadianconsensus-CCC">{{Citation | last = Carruthers | first1 = Bruce M. | authorlink1 = Bruce Carruthers | last2 = Jain | first2 = Anil Kumar | authorlink2 = Anil Kumar Jain | last3 = De Meirleir | first3 = Kenny L. | authorlink3 = Kenny De Meirleir | last4 = Peterson | first4 = Daniel L. | authorlink4 = Daniel Peterson | last5 = Klimas | first5 = Nancy G. | authorlink5 = Nancy Klimas | last6 = Lerner | first6 = A. Martin | authorlink6 = Martin Lerner | last7 = Bested | first7 = Alison C. | authorlink7 = Alison Bested | last8 = Flor-Henry | first8 = Pierre | authorlink8 = Pierre Flor-Henry | last9 = Joshi | first9 = Pradip | authorlink9 = Pradip Joshi | last10 = Powles | first10 = | | isbn = 978-0-9739335-3-6 | url = http://www.investinme.org/Documents/Guidelines/Myalgic%20Encephalomyelitis%20International%20Consensus%20Primer%20-2012-11-26.pdf }}</ref><ref name="canadianconsensus-CCC">{{Citation | last = Carruthers | first1 = Bruce M. | authorlink1 = Bruce Carruthers | last2 = Jain | first2 = Anil Kumar | authorlink2 = Anil Kumar Jain | last3 = De Meirleir | first3 = Kenny L. | authorlink3 = Kenny De Meirleir | last4 = Peterson | first4 = Daniel L. | authorlink4 = Daniel Peterson | last5 = Klimas | first5 = Nancy G. | authorlink5 = Nancy Klimas | last6 = Lerner | first6 = A. Martin | authorlink6 = Martin Lerner | last7 = Bested | first7 = Alison C. | authorlink7 = Alison Bested | last8 = Flor-Henry | first8 = Pierre | authorlink8 = Pierre Flor-Henry | last9 = Joshi | first9 = Pradip | authorlink9 = Pradip Joshi | last10 = Powles | first10 = AC Peter | authorlink10 = AC Peter Powles | last11 = Sherkey | first11 = Jeffrey A. | authorlink11 = Jeffrey Sherkey | last12 = van de Sande | first12 = Marjorie I. | authorlink12 = Marjorie van de Sande| title = Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols | journal =Journal of Chronic Fatigue Syndrome | volume = 11 | issue = 2 | pages = 7-115 | date = 2003 | pmid = | doi = 10.1300/J092v11n01_02 | url = http://www.investinme.org/Documents/PDFdocuments/CanadianDefinitionME-CFS.pdf }}</ref><ref name="fukuda1994">{{Cite journal | last = Fukuda | first = K. |authorlink = Keiji Fukuda | last2 = Straus | first2 = S.E. | authorlink2 = Stephen Straus | last3 = Hickie | first3 = I. | authorlink3 = Ian Hickie | last4 = Sharpe | first4 = M. C. | authorlink4 = Michael Sharpe | last5 = Dobbins | first5 = J. G. | authorlink5 = James Dobbins | last6 = Komaroff | first6 = A. | authorlink6 = Anthony Komaroff | date = 1994-12-15 | title = The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group | url =https://www.researchgate.net/profile/Michael_Sharpe2/publication/247808895_The_Chronic_Fatigue_Syndrome_A_Comprehensive_Approach_to_Its_Definition_and_Study/links/0c96053201643bfc4b000000/The-Chronic-Fatigue-Syndrome-A-Comprehensive-Approach-to-Its-Definition-and-Study.pdf | journal=Annals of Internal Medicine|volume=121|issue=12 | pages = 953–959|issn=0003-4819|pmid=7978722|via=| publisher = American College of Physicians}}</ref> | ||
==Notable articles== | ==Notable articles== |
Revision as of 17:09, November 30, 2022
This article is a stub. |
Gastroesophageal Reflux Disease or Gastro-esophageal Reflux Disease or GERD is a digestive disease, GERD causes stomach contents to rise back up to the esophagus.[1]
Signs and symptoms[edit | edit source]
Treatment[edit | edit source]
Treatment options include , behavioral/lifestyle changes, medication and in some cases surgery.[1]
Over the counter medicals used for gastroesophageal reflux disease include the antacid mix aluminum hydroxide/magnesium hydroxide/simethicone (Almacone, Gelusil, Mi-Acid, Milantex), calcium carbonate (Titralac), and protein pump inhibitors including omeprazole (Prilosec), pantoprazole (Protonix), and famotidine (Pepcid).[2]
Perscription medications for gastroesophageal reflux disease include omeprazole (Prilosec), pantoprazole (Protonix), ranitidine (Zantac, which was withdrawn from the market in the US), famotidine (Pepcid) and metoclopramide.[2]
ME/CFS[edit | edit source]
GERD is not a recognised comorbidity for people with ME/CFS, although acid reflux may occur as part of a set of Digestive symptoms according to the International Consensus Criteria primer for clinicians.[3][4][5]
Notable articles[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
- What Is GERD? - WebMD
- Medications for GERD - drugs.com
References[edit | edit source]
- ↑ 1.0 1.1 "Get the Facts About Gastroesophageal Reflux Disease (GERD)". WebMD. Retrieved March 3, 2021.
- ↑ 2.0 2.1 "List of GERD Medications (83 Compared)". Drugs.com. Retrieved March 3, 2021.
- ↑ Carruthers, BM; van de Sande, MI; De Meirleir, KL; Klimas, NG; Broderick, G; Mitchell, T; Staines, D; Powles, ACP; Speight, N; Vallings, R; Bateman, L; Bell, DS; Carlo-Stella, N; Chia, J; Darragh, A; Gerken, A; Jo, D; Lewis, DP; Light, AR; Light, KC; Marshall-Gradisnik, S; McLaren-Howard, J; Mena, I; Miwa, K; Murovska, M; Stevens, SR (2012), Myalgic encephalomyelitis: Adult & Paediatric: International Consensus Primer for Medical Practitioners (PDF), ISBN 978-0-9739335-3-6
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, AC Peter; Sherkey, Jeffrey A.; van de Sande, Marjorie I. (2003), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols" (PDF), Journal of Chronic Fatigue Syndrome, 11 (2): 7–115, doi:10.1300/J092v11n01_02
- ↑ Fukuda, K.; Straus, S.E.; Hickie, I.; Sharpe, M. C.; Dobbins, J. G.; Komaroff, A. (December 15, 1994). "The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group" (PDF). Annals of Internal Medicine. American College of Physicians. 121 (12): 953–959. ISSN 0003-4819. PMID 7978722.